Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-24 · accession 0001899977-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-26 | 2026-03-24+ | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +14.3K | 61.5K | +30% | — |
| DM | 2026-03-26 | 2026-03-25+ | ACAD | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $21.55 | -7,385 | 57.3K | -11% | -$159.1K |
| DM | 2026-03-26 | 2026-03-24+ | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | $0.00 | -14.3K | 24.4K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-25 | M | A | 6,178 | — | 63,477 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-26 | S | D | 3,171 | $21.65 | 60,306 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-26 | S | D | 37 | $21.72 | 60,269 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-25 | S | D | 4,177 | $21.47 | 57,299 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-24 | M | A | 8,138 | — | 61,476 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 6 | Derivative | Restricted Stock Units | 2026-03-25 | M | D | 6,178 | $0.00 | 12,358 | D | — · — to — | 6,178 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units vest in four equal annual installments beginning March 25, 2025. |
| 7 | Derivative | Restricted Stock Units | 2026-03-24 | M | D | 8,138 | $0.00 | 24,414 | D | — · — to — | 8,138 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The restricted stock units vest in four equal annual installments beginning March 24, 2026. |